Phase 3b, multicenter, randomized, double-blind, parallel-group study to evaluate efficacy and safety of investigational oral edaravone administered over 48 weeks in patients with amyotrophic lateral sclerosis (mt1186-a02)
MUSCLE & NERVE（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要